Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Updated on: January 28,2024 10

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Updated on:January 28,2024 10

Unveiling the New Defense Against COVID-19! Recent Research Identifies the Immune Evasion Mechanism of SARS-CoV-2 and Its Variants

Updated on: June 05,2024 0

Unveiling the New Defense Against COVID-19! Recent Research Identifies the Immune Evasion Mechanism of SARS-CoV-2 and Its Variants

Updated on:June 05,2024 0

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on: April 22,2024 18

SRC-3 is a novel regulator of human immune T regulatory cells

by Baylor College of MedicineSuzanne Judd, Ph.D., an epidemiologist at UAB, explains what will lead to herd immunity and why it is important to remain vigilant in reducing the spread of COVID-19.

Updated on:April 22,2024 18

Having hypermobile joints may increase the risk for depression and anxiety in adolescents

by University of SussexPrevalence of generalized joint hypermobility. (A) Shows the difference in prevalence of GJH in participants who meet diagnostic criteria for ICD-10 depression (blue bar) a

Updated on: May 13,2024 4

Having hypermobile joints may increase the risk for depression and anxiety in adolescents

by University of SussexPrevalence of generalized joint hypermobility. (A) Shows the difference in prevalence of GJH in participants who meet diagnostic criteria for ICD-10 depression (blue bar) a

Updated on:May 13,2024 4

Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

by American College of RheumatologyHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/Wikiped

Updated on: May 23,2024 4

Groundbreaking study reveals clues to predict mortality in rare VEXAS syndrome

by American College of RheumatologyHematopoietic precursor cells: promyelocyte in the center, two metamyelocytes next to it and band cells from a bone marrow aspirate. Credit: Bobjgalindo/Wikiped

Updated on:May 23,2024 4

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Updated on: January 28,2024 18

Research explores environmental pollutant BPA and asthma susceptibility in mice

by PNAS NexusTransmission electron microscopy images demonstrating the effects of BPA on E. coli LPS. Credit: Wang et al.The "hygiene hypothesis" posits that allergic asthma can be triggered

Updated on:January 28,2024 18

Arthritis & the COVID vaccine: What you need to know

(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.Research is limited, but evidence sugg

Updated on: May 13,2024 5

Arthritis & the COVID vaccine: What you need to know

(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.Research is limited, but evidence sugg

Updated on:May 13,2024 5

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on: April 10,2024 14

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

Updated on:April 10,2024 14

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti

Updated on: February 18,2024 23

Study finds TNF blockers are not associated with poor pregnancy outcomes

byAmerican College of RheumatologyCredit: Pixabay/CC0 Public DomainAccording tonew researchatACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeti

Updated on:February 18,2024 23

CRISPR reveals the secret life of antimicrobial peptides

by Ecole Polytechnique Federale de LausanneFruit flies with mutated antimicrobial peptides (red eyes) let bacteria (green fluorescence) grow out of control, while wild-type flies (with normal ant

Updated on: April 12,2024 16

CRISPR reveals the secret life of antimicrobial peptides

by Ecole Polytechnique Federale de LausanneFruit flies with mutated antimicrobial peptides (red eyes) let bacteria (green fluorescence) grow out of control, while wild-type flies (with normal ant

Updated on:April 12,2024 16

Canadian wildfire smoke associated with increased asthma cases in NYC

by Elizabeth Lin,Yale UniversityCredit: Yale UniversityWith smoke from Canadian wildfires once againdescending on the Northeastern United States,residents of New England and New York

Updated on: January 29,2024 13

Canadian wildfire smoke associated with increased asthma cases in NYC

by Elizabeth Lin,Yale UniversityCredit: Yale UniversityWith smoke from Canadian wildfires once againdescending on the Northeastern United States,residents of New England and New York

Updated on:January 29,2024 13

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on: March 02,2024 13

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

Updated on:March 02,2024 13